Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 312 followers
Latest posts
Last updated about 10 hours ago
ArsenalBio lays off 50% of staff in pivot from early-stage research
about 10 hours ago
One of the top fundraisers of 2024 is halving its workforce about...
Dexcom CEO goes on leave while Insulet taps new CFO
about 15 hours ago
The changes at the diabetes tech companies include Dexcom announcing that outgoing...
Following the Apple Watch’s hypertension clearance, FDA warns public against using unauthorized blood pressure tech and baby monitors
about 16 hours ago
The FDA is warning the public to avoid using unreviewed devices for...
VC Aditum launches cardiovascular biotech, offers Mabwell up to $1B for siRNA asset
about 17 hours ago
California VC firm Aditum Bio is at it again, this time partnering...
J&J's IL-23 drug defeats reigning champ Sotyktu in phase 3 psoriasis trial
about 18 hours ago
After being touted as a potential rival to Bristol Myers Squibb’s reigning...
Regeneron reports phase 3 win in ultra-rare disease, bouncing back to spark race to FDA
about 18 hours ago
Regeneron is racing to regulators after reporting a phase 3 win in...
Lilly rounds out oral GLP-1 weight loss data, posts semaglutide-topping results in diabetes
about 19 hours ago
At this year’s meeting of the European Association for the Study of...
Why Sanofi's R&D chief is 'pretty pragmatic' about a 'mixed' year of clinical development
about 19 hours ago
Sanofi’s head of R&D, Houman Ashrafian, Ph.D., spoke to Fierce days before...
Roivant reports phase 3 autoimmune win for ex-Pfizer asset
about 21 hours ago
A phase 3 trial of Priovant Therapeutics’ inflammatory disease prospect brepocitinib has...
Eye disease biotech launches with $100M and sights set on Roche showdown
about 21 hours ago
During his tenure at Genentech, ophthalmologist Jason Ehrlich supported the development of...
Innate to lose 30% of workforce, including CSO, in focus on ‘highest-value assets’
about 22 hours ago
Innate Pharma is set to lose 30% of its employees, including its...
Pharma tells Scotland how to court investment amid UK life sciences turmoil
about 23 hours ago
With drugmakers freezing investment in the U.K., pharma trade group ABPI has...